Cabot (CBT) Cash & Equivalents (2009 - 2026)

Cabot (CBT) has 18 years of Cash & Equivalents data on file, last reported at $252.0 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $252.0 million, up 18.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $252.0 million (up 18.31% YoY), and the FY2025 annual result was $258.0 million, up 15.7% from the prior year.
• Cash & Equivalents grew to $252.0 million in Q1 2026 per CBT's latest filing, from $230.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $258.0 million in Q3 2025 and troughed at $183.0 million in Q4 2024.
• A 5-year average of $219.2 million and a median of $215.0 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents jumped 47.26% in 2022, then slipped 25.0% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $190.0 million in 2022, then climbed by 28.42% to $244.0 million in 2023, then fell by 25.0% to $183.0 million in 2024, then advanced by 25.68% to $230.0 million in 2025, then gained by 9.57% to $252.0 million in 2026.
• Business Quant data shows CBT's Cash & Equivalents at $252.0 million in Q1 2026, $230.0 million in Q4 2025, and $258.0 million in Q3 2025.